Skip to content

KETOgenic diet therapy in patients with HEPatocellular adenoma

Ketogenic diet therapy in patients with Hepatocellular adenoma

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24681
Enrollment
55
Registered
2020-12-04
Start date
2021-02-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Adenoma (HCA), an uncommon, solid, benign liver lesion. Typically, it is a solitary lesion found in young women within their reproductive years.

Interventions

All subjects will receive a diet for 6 months (see table 1 & 2 for the example diet). In this ketogenic diet the amount of carbohydrates is restricted, the first three months to approximately 35 grams

Sponsors

Investigator Initiated
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Age 18-50 years - BMI > 25 kg/m2 - Provide written consent

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: - Current pregnancy or breastfeeding - Diabetes Mellitus type 1 or 2 - Insufficient understanding of the Dutch language - Participation in another clinical study

Design outcomes

Primary

MeasureTime frame
Our main study endpoint is the difference in tumour regression. The size (largest diameter in cm) of the largest hepatocellular adenoma found on MRI will be measured at T0 = time of inclusion and at T5= 6 months after start of the intervention. Mean regression will be calculated after which it will be compared to the regression in tumour size of our (earlier acquired) cohort.

Secondary

MeasureTime frame
Quality of Life, change in body weight, body composition, resting energy expenditure and plasma parameters.

Contacts

Public ContactC.A.J. Oudmaijer

Erasmus MC, University Medical Center Rotterdam

c.oudmaijer@erasmusmc.nl010-7031810

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)